ALKS vs MET · P/E 14, rev $1.56B vs P/E 13, $52.16B cap
Alkermes Plc (ALKS) versus MetLife Inc (MET) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
MetLife Inc (MET) is a insurance - life company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
MET does not have a complete income-statement cache yet.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. MET currently screens at market cap $52.16B and trailing P/E 12.7.
Not investment advice. Open the ALKS and MET stock pages for the full models.
Not investment advice.